¥38.16
¥0.00 (0.00%)
End-of-day quote: 05/10/2024
SZSE:000028

China National Accord Medicines Annual Report

Year Year 2023 2022 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Rev. Revenue
¥75.48B ¥73.44B ¥59.65B ¥52.05B ¥43.12B ¥41.26B ¥41.25B ¥37.82B ¥23.95B ¥21.20B ¥18.01B ¥15.15B ¥13.06B
GM % Gross Margin %
11.93% 12.09% 11.78% 11.01% 11.78% 10.76% 11.13% 11.53% 8.06% 8.16% 8.78% 8.68% 8.65%
OM Operating Margin
3.11% 3.12% 3.25% 3.29% 3.32% 3.11% 3.46% 3.53% 3.68% 3.64% 3.86% 3.26% 2.89%
EPS Earnings Per Share
¥0.00 ¥2.75 ¥2.56 ¥2.46 ¥2.21 ¥2.11 ¥1.86 ¥1.51 ¥1.52 ¥1.37 ¥1.35 ¥1.19 ¥0.83 ¥0.65
Div. Dividends
¥0.68 ¥0.62 ¥0.62 ¥0.31 ¥0.31 ¥0.23 ¥0.25 ¥0.23 ¥0.15 ¥0.14 ¥0.00 ¥0.10 ¥0.00
PR % Payout Ratio %
24.73% 24.22% 25.20% 14.03% 14.69% 12.37% 16.56% 15.13% 10.95% 10.37% 0 12.05% 0
Sha. Shares
556.57m 556.57m 428.13m 428.13m 428.13m 428.13m 362.63m 362.63m 362.63m 288.15m 288.15m 288.15m 288.15m
OCF Operating Cash Flow
¥2.94B ¥2.56B ¥1.50B ¥2.00B ¥1.32B ¥1.29B ¥1.47B ¥1.46B ¥-796.70M ¥465.03M ¥323.96M ¥230.10M ¥428.16M
FCF Free Cash Flow
¥2.61B ¥2.24B ¥1.21B ¥1.76B ¥1.07B ¥1.08B ¥1.23B ¥1.16B ¥-1138.00M ¥319.36M ¥132.77M ¥31.13M ¥250.17M
FCFS Free Cash Flow Per Share
¥4.70 ¥4.02 ¥2.82 ¥4.10 ¥2.49 ¥2.52 ¥2.85 ¥2.74 ¥-3.31 ¥1.09 ¥0.45 ¥0.11 ¥0.87